Search Results - "Ludvigsson, J."

Systematic review with meta‐analysis: associations between coeliac disease and type 1 diabetes by Elfström, P., Sundström, J., Ludvigsson, J. F.

“…Summary Background In the past decade, a number of population‐based studies have examined the prevalence of coeliac disease in individuals with type 1 diabetes…”
Get full text

Direct oral anticoagulant use and risk of severe COVID‐19 by Flam, B., Wintzell, V., Ludvigsson, J. F., Mårtensson, J., Pasternak, B.

“…Background Hypercoagulability and thromboembolism are prominent features of severe COVID‐19, and ongoing anticoagulant use might be protective. Methods We…”
Get full text

Review of 103 Swedish Healthcare Quality Registries by Emilsson, L., Lindahl, B., Köster, M., Lambe, M., Ludvigsson, J. F.

“…Background and objectives In the past two decades, an increasing number of nationwide, Swedish Healthcare Quality Registries (QRs) focusing on specific…”
Get full text

Decrease in primary but not in secondary abdominal surgery for Crohn's disease: nationwide cohort study, 1990–2014 by Kalman, T. D., Everhov, Å. H., Nordenvall, C., Sachs, M. C., Halfvarson, J., Ekbom, A., Ludvigsson, J. F., Myrelid, P., Olén, O.

“…Background Treatment of patients with Crohn's disease has evolved in recent decades, with increasing use of immunomodulatory medication since 1990 and…”
Get full text

Long‐term coeliac disease influences risk of death in patients with type 1 diabetes by Mollazadegan, K., Sanders, D. S., Ludvigsson, J., Ludvigsson, J. F.

“…Aim The aim of this study was to examine mortality in patients with both type 1 diabetes (T1D) and coeliac disease (CD). Methods Between 1969 and 2008, we…”
Get full text

Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12‐year population‐based cohort study by Wikström Shemer, E, Marschall, HU, Ludvigsson, JF, Stephansson, O

“…Objective To determine the risk for adverse pregnancy and fetal outcomes in intrahepatic cholestasis of pregnancy (ICP). Design Population‐based cohort study…”
Get full text

Nationwide prevalence of inflammatory bowel disease in Sweden: a population‐based register study by Büsch, K., Ludvigsson, J. F., Ekström‐Smedby, K., Ekbom, A., Askling, J., Neovius, M.

“…Summary Background Regional studies on inflammatory bowel disease (IBD) suggest an increasing prevalence over time, but no nationwide estimate has been…”
Get full text

Predictors of persistent villous atrophy in coeliac disease: a population‐based study by Lebwohl, B., Murray, J. A., Rubio‐Tapia, A., Green, P. H. R., Ludvigsson, J. F.

“…Summary Background Villous atrophy (VA) with intraepithelial lymphocytosis is the histological hallmark of coeliac disease (CD), but reported rates of mucosal…”
Get full text

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014 by Olén, O, Askling, J, Sachs, MC, Frumento, P, Neovius, M, Smedby, KE, Ekbom, A, Malmborg, P, Ludvigsson, JF

“…Objective To assess risk of cancer in patients with childhood onset inflammatory bowel disease in childhood and adulthood.Design Cohort study with matched…”
Get full text

Clinical management of coeliac disease by Ludvigsson, J. F., Green, P. H.

“…  Ludvigsson JF, Green PH (Örebro University Hospital, Sweden; Clinical Epidemiology Unit, Karolinska University Hospital and Karolinska Institutet, Sweden;…”
Get full text

Risks of neurological and immune‐related diseases, including narcolepsy, after vaccination with Pandemrix: a population‐ and registry‐based cohort study with over 2 years of follow‐up by Persson, I., Granath, F., Askling, J., Ludvigsson, J. F., Olsson, T., Feltelius, N.

“…Objectives To investigate the association between vaccination with Pandemrix and risk of selected neurological and immune‐related diseases including…”
Get full text

Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease by Lamichhane, N., Melas, N., Bergqvist, V., Ekholm, N.-P., Olén, O., Ludvigsson, J. F., Hjortswang, H., Marsal, J., Eriksson, C., Halfvarson, J.

“…Background Real-world data on starting intravenous (IV) vedolizumab (VDZ) and transitioning to subcutaneous (SC) treatment in inflammatory bowel disease (IBD)…”
Get full text

Mucosal healing and mortality in coeliac disease by Lebwohl, B., Granath, F., Ekbom, A., Montgomery, S. M., Murray, J. A., Rubio‐Tapia, A., Green, P. H. R., Ludvigsson, J. F.

“…Summary Background Coeliac disease (CD), characterised by the presence of villous atrophy (VA) in the small intestine, is associated with increased mortality,…”
Get full text

Increased risk of epilepsy in biopsy-verified celiac disease: A population-based cohort study by LUDVIGSSON, J. F, ZINGONE, F, TOMSON, T, EKBOM, A, CIACCI, C

“…Celiac disease (CD) is associated with several neurologic disorders but it is unclear whether CD is associated with epilepsy. We therefore investigated whether…”
Get full text

The importance of factors early in life for development of eating disorders in young people, with some focus on type 1 diabetes by Ludvigsson, J., Olsen Faresjö, Å.

“…Aim Eating disorders have a serious impact on quality of life, especially when combined with Type 1 diabetes. We investigated eating disorders in relation to…”
Get full text

European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1 by Knobler, R., Arenberger, P., Arun, A., Assaf, C., Bagot, M., Berlin, G., Bohbot, A., Calzavara‐Pinton, P., Child, F., Cho, A., French, L.E., Gennery, A.R., Gniadecki, R., Gollnick, H.P.M., Guenova, E., Jaksch, P., Jantschitsch, C., Klemke, C., Ludvigsson, J., Papadavid, E., Scarisbrick, J., Schwarz, T., Stadler, R., Wolf, P., Zic, J., Zouboulis, C., Zuckermann, A., Greinix, H.

“…Background Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T‐cell lymphoma published in…”
Get full text

Quality registries: exciting opportunities by Ludvigsson, J. F.

Get full text

The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease by Emilsson, L., Carlsson, R., Holmqvist, M., James, S., Ludvigsson, J. F.

“…Summary Background Studies have shown an increased risk of ischaemic heart disease (IHD) in patients with coeliac disease (CD), despite the patients' lack of…”
Get full text

Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study by Carlsson, Annelie, Shepherd, Maggie, Ellard, Sian, Weedon, Michael, Lernmark, Åke, Forsander, Gun, Colclough, Kevin, Brahimi, Qefsere, Valtonen-Andre, Camilla, Ivarsson, Sten A, Elding Larsson, Helena, Samuelsson, Ulf, Örtqvist, Eva, Groop, Leif, Ludvigsson, Johnny, Marcus, Claude, Hattersley, Andrew T

“…Identifying maturity-onset diabetes of the young (MODY) in pediatric populations close to diabetes diagnosis is difficult. Misdiagnosis and unnecessary insulin…”
Get full text

Systematic review with meta‐analysis: the prevalence of coeliac disease in patients with osteoporosis by Laszkowska, M., Mahadev, S., Sundström, J., Lebwohl, B., Green, P. H. R., Michaelsson, K., Ludvigsson, J. F.

“…Summary Background Earlier studies have produced highly varying risk estimates for the prevalence of coeliac disease (CD) in osteoporosis. Aims To investigate…”
Get full text